Skip to main content
SpringerLink
Log in

Dobutamine Stress Echocardiography

Safety in Diagnosing Coronary Artery Disease

  • Leading Article
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

Dobutamine stress echocardiography is considered a relatively well-tolerated diagnostic modality, effective in the management of patients with known or suspected coronary artery disease. Adverse effects during testing are relatively frequent, precluding the achievement of a diagnostic end-point in about 5 to 10% of tests. These adverse effects, mostly tachyarrhythmias and arterial hypotension, are usually minor and self limiting. However, severe life-threatening complications, as well as death, also occur.

By analysing Medline-quoted literature up to March 1999, we found 35 original studies from a single institution with more than 100 patients, as well as 2 multicentre studies, concerning the feasibility and safety of dobutamine stress echocardiography. In a cumulative total of 26 438 tests performed, 79 life-threatening complications (such as acute myocardial infarction, asystole, ventricular fibrillation, sustained ventricular tachycardia or severe symptomatic hypotension) have been reported, giving an incidence of 1 severe adverse reaction per every 335 examinations. In addition, 29 isolated case reports have been published describing life-threatening complications during dobutamine echocardiography. In case reports, 2 deaths have been described, both due to acute cardiac rupture in patients with recent inferior myocardial infarction. Severe adverse reactions during dobutamine echocardiography can be ischaemia independent, and are independent of operator experience and are unpredictable; some complications can be late occurring and long lasting. As a consequence, the procedure must be clearly indicated, written informed consent has to be obtained from the patient, an attending physician must be present during testing, and long term observation of outpatients is useful in order to manage late complications.

In conclusion, while the safety of dobutamine stress echocardiography was reported to be outstanding in early reports, further experience presents a substantially more worrying picture. This must be taken into account by both physicians and patients when assessing the risk—benefit profile of the procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Table I
Table II

Similar content being viewed by others

References

  1. Ruffolo RR. The pharmacology of dobutamine. Am J Med 1987; 294: 244–8

    Article  Google Scholar 

  2. Ruffolo Jr RR, Spradlin TA, Pollock GD, et al. Alpha and beta adrenergic effects of the stereoisomers of dobutamine. J Pharmacol Exp Ther 1981; 219: 447–52

    PubMed  CAS  Google Scholar 

  3. Picano E. Pathogenetic mechanism of stress. In: Picano E, editor. Stress echocardiography. 3rd ed. New York: Springer-Verlag, 1997: 62–75

    Google Scholar 

  4. Mason JR, Palac RT, Freeman MC, et al. Thallium scintigraphy during dobutamine infusion: nonexercise-dependent screening test for coronary disease. Am Heart J 1984; 107: 481–5

    Article  PubMed  CAS  Google Scholar 

  5. Berthe C, Pierard LA, Hiernaux M, et al. Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infusion. Am J Cardiol 1986; 58: 1167–72

    Article  PubMed  CAS  Google Scholar 

  6. Cheitlin MS, Alpert JS, Armstrong WF, et al. ACC/AHA guidelines for the clinical application of echocardiography: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol 1997; 29: 862–79

    Article  PubMed  CAS  Google Scholar 

  7. Pierard LA, De Landsheere CM, Berthe C, et al. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990; 15: 1021–31

    Article  PubMed  CAS  Google Scholar 

  8. Geleijnse ML, Fioretti PM, Roelandt JRTC. Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol 1997; 30: 595–606

    Article  PubMed  CAS  Google Scholar 

  9. Picano E. Dobutamine stress echocardiography. In: Picano E, editor. Stress echocardiography. 3rd ed. New York: Springer-Verlag, 1997: 95–102

    Google Scholar 

  10. Sawada SG, Segar DS, Ryan T, et al. Echocardiography detection of coronary artery disease during dobutamine infusion. Circulation 1991; 83: 1605–14

    Article  PubMed  CAS  Google Scholar 

  11. Mazeika PK, Nadazdin A, Oakley CM. Dobutamine stress echocardiography for detection and assessment of coronary artery disease. Am J Cardiol 1992; 69: 1269–73

    Article  Google Scholar 

  12. Mc Neill AJ, Fioretti PM, El-Said EM, et al. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol 1992; 70: 41–6

    Article  CAS  Google Scholar 

  13. Mertes H, Sawada SG, Ryan T, et al. Symptoms, adverse effects and complications associated with dobutamine stress echocardiography: experience in 1118 patients. Circulation 1993; 88: 15–9

    Article  PubMed  CAS  Google Scholar 

  14. Pellikka PA, Roger VL, Oh JJ, et al. Stress echocardiography. Part II: dobutamine stress echocardiography: techniques, implementation, clinical application and correlations. Mayo Clin Proc 1995; 70: 16–27

    PubMed  CAS  Google Scholar 

  15. Zahn R, Lotter R, Nohl H, et al. Feasibility and safety of dobutamine stress echocardiography: experience with 1000 studies. Z Kardiol 1996; 85: 28–34

    PubMed  CAS  Google Scholar 

  16. Lewis WR, Arena FJ, Galloway MT, et al. Acute myocardial infarction associated with dobutamine stress echocardiography. J Am Soc Echocardiogr 1997; 10: 576–8

    Article  PubMed  CAS  Google Scholar 

  17. Seknus MA, Marwick TH. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3011 studies over 5 years. J Am Coll Cardiol 1997; 29: 1234–40

    Article  Google Scholar 

  18. San Roman JA, Vilacosta I, Castillo JA, et al. Dipyridamole and dobutamine-atropine stress echocardiography in the diagnosis of coronary artery disease: comparison with exercise stress test, analysis of agreement, and impact of antianginal treatment. Chest 1996; 110: 1248–54

    Article  PubMed  CAS  Google Scholar 

  19. Hennessy TG, Codd MB, Kane G, et al. Safety of dobutamine stress echocardiography in 474 consecutive studies. Coron Artery Dis 1997; 8: 175–8

    Article  PubMed  CAS  Google Scholar 

  20. Caldellas Capdevila M, Bruguera Cortada J, Hernandez Herrero J, et al. Adverse effects of dobutamine stress echocardiography [in Spanish]. Rev Esp Cardiol 1996; 49: 22–8

    Google Scholar 

  21. Elhendy A, van Domburg RT, Roelandt JR, et al. Safety and feasibility of dobutamine-atropine stress testing in hypertensive patients. Hypertension 1997; 29: 1232–9

    Article  PubMed  CAS  Google Scholar 

  22. Bremer ML, Monaghan KH, Stussy VL, et al. Safety of dobutamine stress echocardiography supervised by registered nurse sonographers. J Am Soc Echocardiogr 1998; 11: 601–5

    Article  PubMed  CAS  Google Scholar 

  23. Cortigiani L, Lombardi M, Landi P, et al. Risk stratification by pharmacological stress echocardiography in a primary care cardiology center. Eur Heart J 1998; 19: 1673–80

    Article  PubMed  CAS  Google Scholar 

  24. Poldermans D, Fioretti PM, Boersma E, et al. Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: a single-center experience. Circulation 1999; 99: 757–62

    Article  PubMed  CAS  Google Scholar 

  25. Bigi R, Partesana N, Verzoni A, et al. Incidence and correlation of complex ventricular arrhythmias during dobutamine stress echocardiography after acute myocardial infarction. Eur Heart J 1995; 16: 1819–24

    PubMed  CAS  Google Scholar 

  26. Lamisse N, Cohen A, Chauvel C, et al. Dobutamine stress echocardiography: monocentric experience of 600 consecutive patients. Influence of age [in French]. Arch Mal Coeur 1997; 90: 1455–61

    PubMed  CAS  Google Scholar 

  27. Cornel JH, Balk AH, Boersma E, et al. Safety and feasibility of dobutamine-atropine stress echocardiography in patients with ischemic left ventricular dysfunction. J Am Soc Echocardiogr 1996; 9; 27–32

    Article  PubMed  CAS  Google Scholar 

  28. Marcovitz PA, Armstrong WF. Accuracy of dobutamine stress echocardiography in detecting coronary artery disease. Am J Cardiol 1992; 69: 1269–73

    Article  PubMed  CAS  Google Scholar 

  29. Takeuchi M, Araki M, Nakashima Y, et al. Comparison of dobutamine stress echocardiography and stress thallium-201 single-photon emission computed tomography for detecting coronary artery disease. J Am Soc Echocardiogr 1993; 6; 593–602

    PubMed  CAS  Google Scholar 

  30. Baudhuin T, Marwick T, Melin J, et al. Diagnosis of coronary artery disease in elderly patients: safety and efficacy of dobutamine echocardiography. Eur Heart J 1993; 14: 799–803

    Article  PubMed  CAS  Google Scholar 

  31. Boccanelli A, Piazza V, Greco C, et al. Diagnostic value and safety of dobutamine echocardiography in the diagnosis of coronary disease [in Italian]. G It Cardiol 1993; 23: 19–28

    CAS  Google Scholar 

  32. Beleslin BD, Ostojic M, Stepanovic J, et al. Stress echocardiography in the detection of myocardial ischemia: head-to-head comparison of exercise, dobutamine, and dipyridamole tests. Circulation 1994; 90: 1168–76

    Article  PubMed  CAS  Google Scholar 

  33. Fetiveau R, Lanzarini L, Poli A, et al. Safety of dobutamine echocardiography stress test [in Italian]. G It Cardiol 1995; 25: 193–201

    CAS  Google Scholar 

  34. Gordon BM, Mohan V, Chapekis AT, et al. An analysis of the safety of performing dobutamine stress echocardiography in an ambulatory setting. J Am Soc Echocardiogr 1995; 8: 15–20

    Article  PubMed  CAS  Google Scholar 

  35. Dagianti A, Penco M, Agati L, et al. Stress echocardiography: comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease. J Am Coll Cardiol 1995; 26: 18–25

    Article  PubMed  CAS  Google Scholar 

  36. Chan RK, Tonkin AM, Byrgiotis S, et al. Assessment of coronary artery disease by dobutamine stress echocardiography. Aust N Z J Med 1995; 25: 707–15

    Article  PubMed  CAS  Google Scholar 

  37. Anthopoulos LP, Bonou MS, Kardaras FG, et al. Stress echocardiography in elderly patients with coronary artery disease: applicability, safety and prognostic value of dobutamine and adenosine echocardiography in elderly patients. J Am Coll Cardiol 1996; 28: 52–9

    Article  PubMed  CAS  Google Scholar 

  38. Pingitore A, Picano E, Quarta Colosso M, et al. The atropine factor in pharmacologic stress echocardiography. J Am Coll Cardiol 1996; 27: 1164–70

    Article  PubMed  CAS  Google Scholar 

  39. Wu CC, Ho YL, Kao SL, et al. Dobutamine stress echocardiography for detecting coronary artery disease. Cardiology 1996; 87: 244–9

    Article  PubMed  CAS  Google Scholar 

  40. Williams MJ, Odabashian J, Laurer MS, et al. Prognostic value of dobutamine echcoardiography in patients with left ventricular dysfunction. J Am Coll Cardiol 1996; 27: 132–9

    Article  PubMed  CAS  Google Scholar 

  41. Ling LH, Pellikka PA, Mahoney DW, et al. Atropine augmentation in dobutamine stress echocardiography: role and incremental value in a clinical practice setting. J Am Coll Cardiol 1996; 28: 551–7

    Article  PubMed  CAS  Google Scholar 

  42. Van Damme H, Pierard L, Gillian D, et al. Cardiac risk assessment before vascular surgery: a prospective study comparing clinical evaluation, dobutamine stress echocardiography and dobutamine Tc-99m sestamibi tomoscintigraphy. Cardiovasc Surg 1997; 5: 54–64

    Article  PubMed  Google Scholar 

  43. Smart SC, Knickelbine T, Stoiber TR, et al. Safety and accuracy of dobutamine-atropine stress echocardiography for the detection of residual stenosis of the infarct-related artery and multivessel disease during first week after acute myocardial infarction. Circulation 1997; 95: 1394–401

    Article  PubMed  CAS  Google Scholar 

  44. Paventi S, Biferali F, Ciavatti M, et al. Feasibility and safety of dobutamine-atropine echocardiography following acute myocardial infarct [in Italian]. Minerva Cardioangiol 1997; 45: 483–8

    PubMed  CAS  Google Scholar 

  45. Hiro J, Hiro T, Reid CL, et al. Safety and results of dobutamine stress echocardiography in women versus men and in patients older and younger than 75 years of age. Am J Cardiol 1997; 80: 1014–20

    Article  PubMed  CAS  Google Scholar 

  46. Pinton R, Lemke W, Garcia LG. Symptoms, complications and hemodynamic changes related to dobutamine stress echocardiography [in Portuguese]. Arq Bras Cardiol 1997; 69: 161–4

    Article  PubMed  CAS  Google Scholar 

  47. Elhendy A, van Domburg RT, Poldermans D, et al. Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test. Diabetes Care 1998; 21: 1797–802

    Article  PubMed  CAS  Google Scholar 

  48. Picano E, Mathias Jr W, Pingitore A, et al. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Lancet 1994; 344: 1190–2

    Article  PubMed  CAS  Google Scholar 

  49. Pezzano A, Gentile F, Mantero A, et al. RITED (Registro Italiano Test Eco-Dobutamina): side effects and complications of echo-dobutamine stress test in 3041 examinations. G It Cardiol 1998; 28: 102–11

    CAS  Google Scholar 

  50. Picano E, Marini C, Pirelli S, et al., on behalf of EPIC study group. Safety of intravenous high dose dipyridamole echocardiography. Am J Cardiol 1992; 70: 252–6

    Article  PubMed  CAS  Google Scholar 

  51. Di Giovanbattista R, Pinelli M, Bafile S, et al. Confronto tra ecostress eco-dipiridamolo ed eco-dobutamina in pazienti con infarto recente e ridotta riserva coronarica [abstract; in Italian]. G It Cardiol 1994; 24Suppl. I: 652

    Google Scholar 

  52. Cohen A, Chauvel C, Benhalima B, et al. Complication of dobutamine stress echocardiography [letter]. Lancet 1995; 345: 201–2

    Article  PubMed  CAS  Google Scholar 

  53. Mathew J, Thannoli N, Narra L, et al. Transmural myocardial ischaemia during dobutamine stress echocardiography [letter]. Lancet 1995; 346: 383–2

    Article  PubMed  CAS  Google Scholar 

  54. Pontillo D, Capezzuto A. Dobutamine, dipyridamole and stress echocardiography [letter]. Circulation 1996; 93: 617

    PubMed  CAS  Google Scholar 

  55. Lanzarini L, Previtali M, Diotallevi P. Syncope caused by cardiac asystole during dobutamine stress echocardiography. Heart 1996; 75: 320–1

    Article  PubMed  CAS  Google Scholar 

  56. Kardaras FG, Bonou MS, Kardaras DF, et al. Dobutamine-induced transmural myocardial ischemia in a patient with mild coronary lesions. Clin Cardiol 1996; 19: 149–51

    Article  PubMed  CAS  Google Scholar 

  57. Madu EC, Price A, Harris T, et al. Sustained nonischemic ventricular tachycardia during dobutamine stress echocardiography. Cardiology 1996; 87: 82–5

    Article  PubMed  CAS  Google Scholar 

  58. Shaheen J, Mendzelevski B, Tzivoni D. Dobutamine-induced ST segment elevation and ventricular fibrillation with non-significant coronary artery disease. Am Heart J 1996; 132: 1058–60

    Article  PubMed  CAS  Google Scholar 

  59. Deligonul U, Armbruster R, Hailu A. Provocation of coronary spasm by dobutamine stress echocardiography in a patient with angiographically minimal coronary artery disease. Clin Cardiol 1996; 19: 755–8

    Article  PubMed  CAS  Google Scholar 

  60. Ferreira AC, de Marchena E, Mayor M, et al. Sinus of Valsalva aneurysm presenting as myocardial infarction during dobutamine stress test. Cathet Cardiovasc Diagn 1996; 39: 400–2

    Article  PubMed  CAS  Google Scholar 

  61. Daniels CJ, Orsinelli DA. Cardiac rupture with dobutamine stress echocardiography. J Am Soc Echocardiogr 1997; 10: 979–81

    Article  PubMed  CAS  Google Scholar 

  62. Weidmann B, Lepique CU, Jansen W, et al. Myocardial infarction as complication of dobutamine stress echocardiography. J Am Soc Echocardiogr 1997; 10: 768–71

    Article  PubMed  CAS  Google Scholar 

  63. Takeuchi M, Sonoda S, Hanada H, et al. Acute myocardial infarction in a patient during dobutamine stress echocardiography. Cathet Cardiovasc Diagn 1997; 41: 404–6

    Article  PubMed  CAS  Google Scholar 

  64. Salustri A, Biferali F, Palamara A. Cardiac arrest during dobutamine stress echocardiography. G It Cardiol 1997; 27: 69–71

    CAS  Google Scholar 

  65. Falsini G, Palmerini L, Forzoni M. Hemorrhagic stroke during dobutamine stress echocardiography: a case report [abstract]. Int Med Clin Lab 1997: 5 213

    Google Scholar 

  66. Giunta L, Borziani S, Trimboli R, et al. Rupture of the interventricular septum after dobutamine stress echocardiography performed 5 days after non complicated acute myocardial infarction: report of a case [abstract]. Int Med Clin Lab 1997: 5: 217

    Google Scholar 

  67. Borziani S, Giunta L, Trimboli R, et al. Cardiac rupture during dobutamine stress echocardiography performed 6 days after non complicated acute myocardial infarction: report of a case [abstract]. Int Med Clin Lab 1997: 5: 217

    Google Scholar 

  68. Tio RA, Van Gelder IC, Boonstra PW, et al. Myocardial bridging in a survivor of sudden cardiac near-death: role of intracoronary Doppler flow measurements and angiography during dobutamine stress in the clinical evaluation. Heart 1997; 77: 280–2

    Article  PubMed  CAS  Google Scholar 

  69. Pinton R, Haggi Filho H, Lemke W, et al. Cardiac asystole during dobutamine stress echocardiography. Arq Bras Cardiol 1998; 70: 435–6

    Article  PubMed  CAS  Google Scholar 

  70. Yamagishi H, Watanabe H, Toda I, et al. A case of dobutamine-induced coronary arterial spasm with ST-segment elevation. Jpn Circ J 1998; 62: 150–1

    Article  PubMed  CAS  Google Scholar 

  71. Reisenhofer B, Squarcini G, Picano E. Cardiac rupture during dobutamine stress test [letter]. Ann Intern Med 1998; 128: 605

    PubMed  CAS  Google Scholar 

  72. Breithardt OA, Flachskampf FA, Klues HG. Life threatening acute complications of dobutamine-atropine stress echocardiography - a case report [in German]. Z Kardiol 1998; 87: 492–8

    Article  PubMed  CAS  Google Scholar 

  73. Andrade MJ, Trabulo M, Gouveia R, et al. Feasibility, safety and limiting side effects of pharmacological stress echocardiography: evaluation of different protocols at a single center [abstract]. Echocardiography 1998; 15: S53

    Google Scholar 

  74. Poldermans D, ten Cate FJ, Elhendy A, et al. Ventricular tachycardia during dobutamine stress myocardial contrast imaging [letter]. Chest 1999; 115: 307–8

    Article  PubMed  CAS  Google Scholar 

  75. Bianchi F, Bollini R, Lupi G. Rottura di setto interventricolare in corso di eco-dobutamina in paziente con recente infarto miocardico: descrizione di un caso. [in Italian] IX Congress of Italian Society of Echocardiography. Abstract book. 1999 April 19-23; Milan, Syntagma Publ., 1999: 280

    Google Scholar 

  76. Varga A, Lakatos F, Picano E. Fatal ventricular fibrillation during low-dose dobutamine stress [letter]. Am J Med. In press

  77. Orlandini ADO, Tuero EI, Diaz R, et al. Acute cardiac rupture during dobutamine-atropine echocardiography stress test. J Am Soc Echocardiogr 2000; 13: 152–3

    PubMed  CAS  Google Scholar 

  78. Beckmann SH, Haug G. National registry 1995-1998 on 150,000 Stress Echo examinations: side effects and complications in 60,448 examinations of the registry 1997-1998 [abstract]. Circulation 1999; 100(8) Suppl.: 3401

    Google Scholar 

  79. Varga A, Cseh E, Picano E. International “Stress Echo Horror Poll” registry: “ad interim” results on 47 858 examinations [abstract]. Eur Heart J 1999: 20(Abstr. Suppl.): P3630

    Google Scholar 

  80. Coma-Canella I. Changes in plasma potassium during dobutamine stress test. Int J Cardiol 1991; 33: 55–60

    Article  PubMed  CAS  Google Scholar 

  81. Tanimoto M, Pai RG, Jintapakorn W, et al. Mechanism of hypotension during dobutamine stress echocardiography in patients with coronary artery disease. Am J Cardiol 1995; 76: 26–30

    Article  PubMed  CAS  Google Scholar 

  82. Galloway MT, Paglieroni TG, Wun T, et al. Platelet activation during dobutamine stress echocardiography. Am Heart J 1998; 135: 888–900

    Article  PubMed  CAS  Google Scholar 

  83. Mathias Jr W, Arruda A, Santos FC. et al. Safety of dobutamine-atropine stress echocardiography: a prospective experience of 4033 consecutive studies. JASE 1999; 12: 785–91

    Google Scholar 

  84. Ellestad MH. Contraindications, risks and safety measures. In: Ellestad MH, editor. Exercise stress testing: principles and practice. 4th ed. Philadelphia: Davies Publications, 1996

    Google Scholar 

  85. Michael TAD, Antonescu A, Bhambi B, et al. Accuracy and usefulness of atrial pacing in conjunction with transthoracic echocardiography in the detection of cardiac ischemia. Am J Cardiol 1996; 77: 187–90

    Article  PubMed  CAS  Google Scholar 

  86. Picano E, Trivieri MG. Pharmacological stress echocardiography in the assessment of coronary disease. Curr Opin Cardiol 1999; 14: 464–70

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Research Council, Institute of Clinical Physiology, University of Pisa, CNR, Via Paolo Savi 8, 56123, Pisa, Italy

    Fabio Lattanzi &  Eugenio Picano

  2. Negrar Hospital, Verona, Italy

    Edoardo Adamo & Albert Varga

Authors
  1. Fabio Lattanzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eugenio Picano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Edoardo Adamo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Albert Varga
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eugenio Picano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lattanzi, F., Picano, E., Adamo, E. et al. Dobutamine Stress Echocardiography. Drug-Safety 22, 251–262 (2000). https://doi.org/10.2165/00002018-200022040-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200022040-00001

Keywords

Search

Navigation